Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 1
|
pp. 351–363
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration
Back to article
Figure 6
(6 of 6)
−
100%
+
Figure 6.
VEGFR1-specific signaling pathway that HIF1A participates in.
VEGFR1, vascular endothelial growth factor receptor 1; HIF1A, hypoxia-inducible factor 1.